From the Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts; the Division of Genetics, Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts; the Department of Pathology and Laboratory Medicine, Women and Infants Hospital and the Alpert School of Medicine at Brown University, Providence, Rhode Island; the Institute of Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts; and the Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York.
Obstet Gynecol. 2010 Sep;116(3):673-678. doi: 10.1097/AOG.0b013e3181ea2dd1.
To assess the relationship between first- and second-trimester cell-free DNA levels and maternal serum screening markers.
First- and second-trimester residual maternal serum samples from 50 women were obtained. First-trimester (pregnancy-associated plasma protein A and beta-hCG) and second-trimester serum analytes (beta-hCG, alpha-fetoprotein, unconjugated estriol, and inhibin A) had been measured at the time of sample receipt. All fetuses were male as confirmed by birth records. Cell-free DNA was extracted and measured by real-time quantitative polymerase chain reaction amplification using glyceraldehyde phosphate dehydrogenase and DYS1 as markers of total DNA and fetal DNA, respectively. Determination of linear associations between first- and second-trimester serum markers and cell-free DNA levels using Pearson correlations was performed.
Statistically significant correlations between first-trimester pregnancy-associated plasma protein A multiples of the median and both total (r=0.36, P=.016) and fetal (r=0.41, P=.006) DNA in the first trimester were observed. There were no significant correlations between first-trimester serum human chorionic gonadotropin or any second-trimester serum marker with DNA levels.
Correlation between serum pregnancy-associated plasma protein A and first-trimester circulating cell-free fetal and total DNA levels is a novel finding. Pregnancy-associated plasma protein A is a glycoprotein of placental origin, and its correlation to cell-free fetal DNA in maternal serum suggests a common tissue origin through apoptosis of placental cells. However, because pregnancy-associated plasma protein A and cell-free DNA were only marginally correlated and cell-free DNA can be reliably detected in the first trimester, the addition of cell-free DNA to serum screening strategies may be helpful in predicting adverse pregnancy outcome.
II.
评估早、中孕期游离 DNA 水平与母血清筛查标志物之间的关系。
收集 50 例女性的早、中孕期剩余母血清样本。在收到样本时,已检测了早孕期(妊娠相关血浆蛋白 A 和β-HCG)和中孕期血清分析物(β-HCG、甲胎蛋白、未结合雌三醇和抑制素 A)。所有胎儿均为男性,这是通过出生记录确认的。通过实时定量聚合酶链反应扩增,使用甘油醛磷酸脱氢酶和 DYS1 分别作为总 DNA 和胎儿 DNA 的标志物,提取并测量游离 DNA。使用 Pearson 相关性分析确定早、中孕期血清标志物与游离 DNA 水平之间的线性关联。
早孕期妊娠相关血浆蛋白 A 倍数与总 DNA(r=0.36,P=.016)和胎儿 DNA(r=0.41,P=.006)在早孕期均存在显著相关性。早孕期血清人绒毛膜促性腺激素或任何中孕期血清标志物与 DNA 水平之间均无显著相关性。
血清妊娠相关血浆蛋白 A 与早孕期循环游离胎儿和总 DNA 水平之间的相关性是一个新发现。妊娠相关血浆蛋白 A 是胎盘来源的糖蛋白,其与母血清中游离胎儿 DNA 的相关性提示共同的组织起源,即胎盘细胞凋亡。然而,由于妊娠相关血浆蛋白 A 和游离 DNA 仅呈边缘相关,且游离 DNA 可在早孕期可靠检测到,因此将游离 DNA 加入血清筛查策略可能有助于预测不良妊娠结局。
II。